Citations

Mayo Clinic

Showing 10 of 108551 citations.

Circulating cellular adhesion molecules and risk of diabetes: the Multi‐Ethnic Study of Atherosclerosis (MESA)
Pankow, James S. , Decker, Paul A. , Berardi, Cecilia , Hanson, Naomi Q., Sale, Michèle M. , Tang, Weihong , Tsai, Michael Y. , Wassel, Christina L. , Bielinski, Suzette J. , Decker, Paul A. , Kanaya, Alka M , Larson, Nicholas B. , Bielinski, Suzette , Pankow, James S , Tang, Weihong

Diabetic Medicine | March 3, 2016 | Volume: 33 | Issue: 7 | Pages: 985-991

10.1111/dme.13108 | PMID 26937608 Get It

AbstractAimsTo test the hypothesis that soluble cellular adhesion molecules would be positively and independently associated with risk of diabetes.MethodsSoluble levels of six cellular adhesion molecules (ICAM‐1, E‐selectin, VCAM‐1, E‐cadherin, L‐selectin and P‐selectin) were measured in participants in the Multi‐Ethnic Study of Atherosclerosis, a prospective cohort study. Participants were then followed for up to 10 years to ascertain incident diabetes.ResultsSample sizes ranged from 826 to 2185. After adjusting for age, sex, race/ethnicity, BMI and fasting glucose or HbA1c, four cellular adhesion molecules (ICAM‐1, E‐selectin, VCAM‐1 and E‐cadherin) were positively associated with incident diabetes and there was a statistically significant trend across quartiles. Comparing the incidence of diabetes in the highest and lowest quartiles of each cellular adhesion molecule, the magnitude of association was largest for E‐selectin (hazard ratio 2.49; 95% CI 1.26–4.93) and ICAM‐1 (hazard ratio 1.76; 95% CI 1.22–2.55) in fully adjusted models. Tests of effect modification by racial/ethnic group and sex were not statistically significant for any of the cellular adhesion molecules (P > 0.05).ConclusionsThe finding of significant associations between multiple cellular adhesion molecules and incident diabetes may lend further support to the hypothesis that microvascular endothelial dysfunction contributes to risk of diabetes.
Ureteroarterial Fistulas After Robotic and Open Radical Cystectomy
Palmerola, Ricardo, Westerman, Mary E. , Fakhoury, Mathew, Boorjian, Stephen A. , Richstone, Lee, Westerman, Mary E

Journal of Endourology Case Reports | March 3, 2016 | Volume: 2 | Issue: 1 | Pages: 48-51

10.1089/cren.2015.0034 | PMID 27579415 Get It

Ureteroarterial fistulas (UAFs) are defined as an abnormal communication between one of the major arteries and the ureter. Urologists most frequently encounter iatrogenic fistulas occurring in patients with a history of pelvic extirpative surgery, chronic ureteral catheterization, and history of pelvic radiation. We present two cases of UAFs in patients with no history of prior radiation, who underwent open radical cystectomy and robot-assisted radical cystectomy with intracorporeal ileal conduit. Both patients developed postoperative ureteroileal anastomotic leaks that were managed with indwelling ureteral catheters. Furthermore, both patients were having left-sided UAF after presenting with nonlife threatening gross hematuria, which became brisk and pulsatile during ureteral stent exchange. Endovascular stenting was performed in both patients with resolution of hemorrhage and full recovery. In one patient, nephrostomy tubes were placed and ureteral catheters were removed; the second patient was managed with continued ureteral catheterization without further episodes of hematuria.
Factors Influencing Selection of Vaginal, Open Abdominal, or Robotic Surgery to Treat Apical Vaginal Vault Prolapse
Anand, Mallika , Weaver, Amy L. , Fruth, Kristin M. , Gebhart, John B.

Female Pelvic Medicine & Reconstructive Surgery | March 3, 2016 | Volume: 22 | Issue: 4 | Pages: 236-242

10.1097/spv.0000000000000264 | PMID 26945273 Get It

Objectives This study aimed to determine factors influencing the selection of Mayo-McCall culdoplasty (MMC), open abdominal sacrocolpopexy (ASC), or robotic sacrocolpopexy (RSC) for posthysterectomy vaginal vault prolapse. Methods We retrospectively searched for the records of patients undergoing posthysterectomy apical vaginal prolapse surgery between January 1, 2000, and June 30, 2012, at our institution. Baseline characteristics and explicit selection factors were abstracted from the electronic medical records. Factors were compared between groups using χ2 tests for categorical variables, analysis of variance for continuous variables, and Kruskal-Wallis tests for ordinal variables. Results Among the 512 patients identified who met inclusion criteria, the MMC group (n = 174) had more patients who were older, had American Society of Anesthesiologists class 3+ or greater, had anterior vaginal prolapse grade 3+, desired to avoid abdominal surgery, and did not desire a functional vagina. Patients in the ASC (n = 237) and RSC (n = 101) groups had more failed prolapse surgeries, suspected abdominopelvic pathologic processes, and chronic pain. Advanced prolapse was more frequently cited as an explicit selection factor for ASC than for either MMC or RSC. Conclusions The most common factors that influenced the type of apical vaginal vault prolapse surgery overlapped with characteristics that differed at baseline. In general, MMC was chosen for advanced anterior vaginal prolapse and baseline characteristics that increased surgical risks, ASC for advanced apical prolapse, and ASC or RSC for recurrent prolapse, suspected abdominal pathology, and patients with chronic pain or lifestyles including heavy lifting. Thus, efforts should be made to attempt to control for selection bias when comparing these procedures.
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions
Czaja, Albert J.

Gut and Liver | March 3, 2016 | Volume: 10 | Issue: 2 | Pages: 177

10.5009/gnl15352 | PMID 26934884 Get It

Geographic Distribution and Evolution of Thyroid Cancer Epidemic in South Korea
Brito, Juan P. , Kim, Hyun Jung , Han, Seung Jin , Lee, Young Sung , Ahn, Hyeong Sik , Brito, Juan P

Thyroid® | March 3, 2016 | Volume: 26 | Issue: 6 | Pages: 864-865

10.1089/thy.2016.0057 | PMID 26934819 Get It

APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations
Shinohara, Mitsuru , Kanekiyo, Takahisa , Yang, Longyu, Linthicum, Duane, Shinohara, Motoko, Fu, Yuan , Frisch‐Daiello, Jessica L., Fryer, John Denis , Bu, Guojun , Price, Laura, Fryer, John D., Price, Laura, Han, Xianlin , Bu, Guojun

Annals of Neurology | March 2, 2016 | Volume: 79 | Issue: 5 | Pages: 758-774

10.1002/ana.24628 | PMID 26933942 Get It

ObjectiveApolipoprotein E (apoE), a major cholesterol carrier in the brain, is associated with a strong risk for Alzheimer disease. Compared to the risky APOE4 gene allele, the effects of the protective APOE2 gene allele are vastly understudied, and thus need to be further clarified.MethodsWe reviewed National Alzheimer's Coordinating Center clinical records and performed preclinical experiments using human apoE‐targeted replacement (apoE‐TR) mice, which do not show amyloid pathology.ResultsClinically, the APOE2 allele was associated with less cognitive decline during aging. This effect was also seen in subjects with little amyloid pathology, or after adjusting for Alzheimer disease‐related pathologies. In animal studies, aged apoE2‐TR mice also exhibited preserved memory function in water maze tests. Regardless, apoE2‐TR mice showed similar or greater age‐related changes in synaptic loss, neuroinflammation, and oxidative stress compared to apoE3‐TR or apoE4‐TR mice. Interestingly, apoE concentrations in the cortex, hippocampus, plasma, and cerebrospinal fluid (CSF) were positively correlated with memory performance across apoE isoforms, where apoE2‐TR mice had higher apoE levels. Moreover, apoE2‐TR mice exhibited the lowest levels of cholesterol in the cortex, despite higher levels in CSF and plasma. These cholesterol levels were associated with apoE levels and memory performance across apoE isoforms.InterpretationAPOE2 is associated with less cognitive decline during aging. This can occur independently of age‐related synaptic/neuroinflammatory changes and amyloid accumulation. Higher levels of apoE and associated cholesterol metabolism in APOE2 carriers might contribute to this protective effect. Ann Neurol 2016;79:758–774
Turning BiKEs into TriKEs to fight cancer
Dronca, Roxana

Science Translational Medicine | March 2, 2016 | Volume: 8 | Issue: 328 | Pages: No page available

10.1126/scitranslmed.aaf3855 Get It

Incorporation of IL-15 into a bispecific antibody recognizing CD16 and CD33 boosted natural killer cells’ survival and activity against acute myeloid leukemia.
High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
Howat, William , Daley, Frances , Zabaglo, Lila, McDuffus, Leigh‐Anne, Blows, Fiona M., Coulson, Penny , Ali, H. Raza , Benı́tez, Javier , Brenner, Hermann , Stegmaier, Christa, Mannermaa, Arto, Chang‐Claude, Jenny , Sinn, Hans‐Peter , Tollenaar, Rob A.�E.�M. , Devilee, Peter , Figueroa, Jonine D. , Sherman, Mark E., Lissowska, Jolanta , Hewitt, Stephen M. , Eccles, Diana , Hooning, Maartje J. , Deurzen, Carolien HM van, Investigators, kConFab, Bolla, Manjeet K. , Wang, Qin , Jones, Michael E. , Schoemaker, Minouk J. , Leeuwen, Flora E. van , Veer, Laura van’t, Swerdlow, Anthony J. , Orr, Nick , Dowsett, Mitch , Easton, Douglas F. , Schmidt, Marjanka K. , García‐Closas, Montserrat , Abubakar, Mustapha , Milne, Roger L. , Mannermaa, Arto, Rudolph, Anja , Couch, Fergus J. , Hollestelle, Antoinette , Martens, John W.M. , Deurzen, Carolien HM van, Broeks, Annegien , Pharoah, Paul D.P. , Eccles, Diana , Swerdlow, Anthony J , Lissowska, Jolanta , Sinn, Peter , Jones, Michael E , Brenner, Hermann , García-Closas, Montserrat , Schmidt, Marjanka K , Benitez, Javier , Figueroa, Jonine D , Devilee, Peter , Schoemaker, Minouk J , Orr, Nick

The Journal of Pathology: Clinical Research | March 2, 2016 | Volume: 2 | Issue: 3 | Pages: 138-153

10.1002/cjp2.42 | PMID 27499923 Get It

AbstractAutomated methods are needed to facilitate high‐throughput and reproducible scoring of Ki67 and other markers in breast cancer tissue microarrays (TMAs) in large‐scale studies. To address this need, we developed an automated protocol for Ki67 scoring and evaluated its performance in studies from the Breast Cancer Association Consortium. We utilized 166 TMAs containing 16,953 tumour cores representing 9,059 breast cancer cases, from 13 studies, with information on other clinical and pathological characteristics. TMAs were stained for Ki67 using standard immunohistochemical procedures, and scanned and digitized using the Ariol system. An automated algorithm was developed for the scoring of Ki67, and scores were compared to computer assisted visual (CAV) scores in a subset of 15 TMAs in a training set. We also assessed the correlation between automated Ki67 scores and other clinical and pathological characteristics. Overall, we observed good discriminatory accuracy (AUC = 85%) and good agreement (kappa = 0.64) between the automated and CAV scoring methods in the training set. The performance of the automated method varied by TMA (kappa range= 0.37–0.87) and study (kappa range = 0.39–0.69). The automated method performed better in satisfactory cores (kappa = 0.68) than suboptimal (kappa = 0.51) cores (p‐value for comparison = 0.005); and among cores with higher total nuclei counted by the machine (4,000–4,500 cells: kappa = 0.78) than those with lower counts (50–500 cells: kappa = 0.41; p‐value = 0.010). Among the 9,059 cases in this study, the correlations between automated Ki67 and clinical and pathological characteristics were found to be in the expected directions. Our findings indicate that automated scoring of Ki67 can be an efficient method to obtain good quality data across large numbers of TMAs from multicentre studies. However, robust algorithm development and rigorous pre‐ and post‐analytical quality control procedures are necessary in order to ensure satisfactory performance.
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
Funder, John W. , Carey, Robert M. , Mantero, Franco , Murad, M. Hassan , Reincke, Martín , Shibata, Hirotaka , Stowasser, Michael , Young, William F. , Murad, M Hassan

The Journal of Clinical Endocrinology & Metabolism | March 2, 2016 | Volume: 101 | Issue: 5 | Pages: 1889-1916

10.1210/jc.2015-4061 | PMID 26934393 Get It

AbstractObjective:To develop clinical practice guidelines for the management of patients with primary aldosteronism.Participants:The Task Force included a chair, selected by the Clinical Guidelines Subcommittee of the Endocrine Society, six additional experts, a methodologist, and a medical writer. The guideline was cosponsored by American Heart Association, American Association of Endocrine Surgeons, European Society of Endocrinology, European Society of Hypertension, International Association of Endocrine Surgeons, International Society of Endocrinology, International Society of Hypertension, Japan Endocrine Society, and The Japanese Society of Hypertension. The Task Force received no corporate funding or remuneration.Evidence:We searched for systematic reviews and primary studies to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation group criteria to describe both the quality of evidence and the strength of recommendations. We used “recommend” for strong recommendations and “suggest” for weak recommendations.Consensus Process:We achieved consensus by collecting the best available evidence and conducting one group meeting, several conference calls, and multiple e-mail communications. With the help of a medical writer, the Endocrine Society's Clinical Guidelines Subcommittee, Clinical Affairs Core Committee, and Council successfully reviewed the drafts prepared by the Task Force. We placed the version approved by the Clinical Guidelines Subcommittee and Clinical Affairs Core Committee on the Endocrine Society's website for comments by members. At each stage of review, the Task Force received written comments and incorporated necessary changes.Conclusions:For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions and recommend that a commonly used confirmatory test should confirm/exclude the condition. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend that an experienced radiologist should establish/exclude unilateral primary aldosteronism using bilateral adrenal venous sampling, and if confirmed, this should optimally be treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia or those unsuitable for surgery should be treated primarily with a mineralocorticoid receptor antagonist.
Creation of the Prevention of Organ Failure Checklist. A Multidisciplinary Approach Using the Modified Delphi Technique
Pearl, Joshua, Dong, Yue , Herasevich, Vitaly , Gong, Michelle N. , Gajic, Ognjen , Herasevich, Vitaly , Dong, Yue

Annals of the American Thoracic Society | March 2, 2016 | Volume: 13 | Issue: 6 | Pages: 910-916

10.1513/annalsats.201509-626bc | PMID 26933899 Get It

Abstract Rationale Respiratory failure represents a major risk for morbidity and mortality. Although generally managed in the intensive care unit (ICU), respiratory failure often begins elsewhere. Checklists of care processes to minimize the duration of mechanical ventilation and adverse events are routinely used in the ICU, but are uncommonly used outside the ICU. Objectives To develop consensus among a multidisciplinary expert panel on care practices to include in a checklist of best practices for critically ill patients with respiratory failure before and after ICU admission. Methods A multidisciplinary expert panel was assembled. The panel was tasked with creating a checklist of care processes aimed at decreasing progression to respiratory failure, duration of mechanical ventilation, mortality in mechanical ventilation, and adverse events. Over the course of multiple teleconferences and e-mail communications, the Prevention of Organ Failure Checklist list was reviewed, refined, and voted upon. Items that received greater than 75% of the vote were included in the final checklist. Measurements and Main Results: Using a modified Delphi process, the expert panel was able to compile Prevention of Organ Failure Checklist into 20 items that aimed to decrease mechanical ventilation by assessing the causes of acute respiratory failure, ventilation strategies, sedation, and general critical care processes, as well as to avoid unwanted or nonbeneficial interventions. Conclusions The modified Delphi process identified readily available preventative interventions suitable for checklist implementation in patients with or progressing to respiratory failure even before ICU admission.